CoChat

RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

Open access
Cotto, Kelsy C., Feng, Yang-Yang, Ramu, Avinash, Richters, Megan, Freshour, Sharon L., Skidmore, Zachary L., Xia, Huiming, McMichael, Joshua F., Kunisaki, Jason, Campbell, Katie M., Chen, Timothy Hung-Po, Rozycki, Emily B., Adkins, Douglas, Devarakonda, Siddhartha, Sankararaman, Sumithra, Lin, Yiing, Chapman, William C., Maher, Christopher A., Arora, Vivek, Dunn, Gavin P., Uppaluri, Ravindra, Govindan, Ramaswamy, Griffith, Obi L., Griffith, Malachi · 2018 · bioRxiv (Cold Spring Harbor Laboratory)

Preprint — published as 10.1038/s41467-023-37266-6

PreprintCited by 55

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Somatic mutations within non-coding regions and even exons may have unidentified regulatory consequences that are often overlooked in analysis workflows. Here we present RegTools ( www.regtools.org ), a computationally efficient, free, and open-source software package designed to integrate somatic variants from genomic data with splice junctions from bulk or single cell transcriptomic data to identify variants that may cause aberrant splicing. RegTools was applied to over 9,000 tumor samples with both tumor DNA and RNA sequence data. We discovered 235,778 events where a splice-associated variant significantly increased the splicing of a particular junction, across 158,200 unique variants and 131,212 unique junctions. To characterize these somatic variants and their associated splice isoforms, we annotated them with the Variant Effect Predictor (VEP), SpliceAI, and Genotype-Tissue Expression (GTEx) junction counts and compared our results to other tools that integrate genomic and transcriptomic data. While many events were corroborated by the aforementioned tools, the flexibility of RegTools also allowed us to identify novel splice-associated variants and previously unreported patterns of splicing disruption in known cancer drivers, such as TP53, CDKN2A , and B2M , as well as in genes not previously considered cancer-relevant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/436634

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 78

  1. 10.1083/jcb.201510032 · DOI · Paper page
  2. 10.1126/science.1235122 · DOI · Paper page
  3. 10.1038/ng.3837 · DOI · Paper page
  4. 10.1016/j.cell.2014.01.051 · DOI · Paper page
  5. 10.1038/ng.3414 · DOI · Paper page
  6. 10.1158/0008-5472.CAN-04-1910 · DOI · Paper page
  7. 10.1016/j.celrep.2017.08.012 · DOI · Paper page
  8. 10.1038/onc.2013.570 · DOI · Paper page
  9. 10.1126/science.1254806 · DOI · Paper page
  10. 10.1089/1066527041410418 · DOI · Paper page
  11. 10.1126/science.1073774 · DOI · Paper page
  12. 10.1016/j.cell.2004.11.010 · DOI · Paper page
  13. 10.1016/J.CELL.2018.12.015 · DOI · Paper page
  14. 10.1093/bioinformatics/btw076 · DOI · Paper page
  15. 10.1186/s13059-018-1417-1 · DOI · Paper page
  16. 10.1016/j.ccell.2018.07.001 · DOI · Paper page
  17. 10.1038/ncomms5698 · DOI · Paper page
  18. 10.1126/science.aad9417 · DOI · Paper page
  19. 10.1016/j.celrep.2018.03.052 · DOI · Paper page
  20. Viner, C. , Dorman, S. N. , Shirley, B. C. & Rogan, P. K. Validation of predicted mRNA splicing mutations using high-throughput transcriptome data. F1000Res. 3, (2014). · DOI
  21. 2018, Pan-cancer repository of validated natural and cryptic mRNA splicing mutations, F1000Res, 7, 1908, 10.12688/f1000research.17204.1 · DOI
  22. 10.1101/gr.231951.117 · DOI
  23. 10.1038/ng.2653 · DOI · Paper page
  24. 10.1186/s13059-016-0974-4 · DOI · Paper page
  25. 10.1093/bioinformatics/btp352 · DOI · Paper page
  26. 10.1038/nbt.1754 · DOI · Paper page
  27. 2021, MutSpliceDB: A database of splice sites variants with RNA-seq based evidence on effects on splicing, Hum. Mutat, 42, 342, 10.1002/humu.24185 · DOI
  28. 10.1038/nature11003 · DOI · Paper page
  29. 2017, Detection of homozygous deletions in tumorsuppressor genes ranging from dozen to hundreds nucleotides in cancer models, Hum. Mutat, 38, 1449, 10.1002/humu.23308 · DOI
  30. 10.1158/2159-8290.CD-21-0291 · DOI · Paper page
  31. 10.1038/s41467-018-06162-9 · DOI · Paper page
  32. Sato, Y. et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight 3, (2018). · DOI
  33. 10.1093/nar/gkaa1100 · DOI · Paper page
  34. 10.1038/sj.emboj.7600475 · DOI · Paper page
  35. 10.1002/jcb.23222 · DOI
  36. 2007, Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival, Cancer Biol. Ther, 6, 192, 10.4161/cbt.6.2.3587 · DOI · Paper page
  37. 2009, Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma, Pediatr. Blood Cancer, 53, 332, 10.1002/pbc.22068 · DOI
  38. 10.1023/A:1015583310759 · DOI
  39. 2021, Identification of prognostic alternative splicing signatures in uveal melanoma, Int. Ophthalmol, 41, 1347, 10.1007/s10792-021-01699-z · DOI
  40. 10.2147/OTT.S53876 · DOI · Paper page
  41. 2019, CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers, Cell Syst, 9, 9, 10.1016/j.cels.2019.05.005 · DOI · Paper page
  42. 2021, Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis, Front. Immunol, 12, 613530, 10.3389/fimmu.2021.613530 · DOI
  43. 2019, IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway, Biomed Res. Int, 2019, 7201562
  44. 2021, IGHG1 induces EMT in gastric cancer cells by regulating TGF-β/SMAD3 signaling pathway, J. Cancer, 12, 3458, 10.7150/jca.56056 · doi:10.7150/jca.56056
  45. 2021, IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway, Cancer Cell Int, 21, 397, 10.1186/s12935-021-02098-1 · doi:10.1186/s12935-021-02098-1
  46. Bonneville, R. et al. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol 2017, (2017). · DOI · Paper page
  47. 10.1158/0008-5472.CAN-05-0044 · DOI · Paper page
  48. 10.1016/S0167-5699(00)01692-3 · DOI · Paper page
  49. 1987, The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit, J. Immunol, 139, 3132, 10.4049/jimmunol.139.9.3132 · DOI · Paper page
  50. 2017, E3 ubiquitin ligase, RNF139, inhibits the progression of tongue cancer, BMC Cancer, 17, 452, 10.1186/s12885-017-3438-7 · doi:10.1186/s12885-017-3438-7
  51. 10.1093/nar/gku1267 · DOI · Paper page
  52. 10.1074/jbc.C200622200 · DOI · Paper page
  53. 10.1093/bioinformatics/bts635 · DOI · Paper page
  54. 10.1038/nmeth.3317 · DOI · Paper page
  55. 10.1186/gb-2013-14-4-r36 · DOI · Paper page
  56. 2018, Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines, Cell Syst, 6, 271, 10.1016/j.cels.2018.03.002 · DOI · Paper page
  57. 10.3727/105221615X14399878166113 · DOI
  58. 2021, GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients, Sci. Rep, 11, 1679, 10.1038/s41598-020-80680-9 · DOI
  59. 10.1261/rna.876308 · DOI · Paper page
  60. 10.1128/MCB.19.4.2657 · DOI · Paper page
  61. 10.1128/MCB.19.1.261 · DOI · Paper page
  62. 10.1073/pnas.0501414102 · doi:10.1073/pnas.0501414102
  63. 10.1002/0471250953.bi1112s47 · DOI · Paper page
  64. 10.1093/bioinformatics/btq671 · DOI · Paper page
  65. 10.1038/nbt.3519 · DOI · Paper page
  66. 10.1093/bioinformatics/bty191 · DOI · Paper page
  67. 10.1101/055467 · doi:10.1101/055467
  68. 10.1038/nbt.2514 · DOI · Paper page
  69. 10.1101/gr.129684.111 · DOI · Paper page
  70. 10.1093/bioinformatics/btr665 · DOI · Paper page
  71. 2022, Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers, Cancer Genet, 264-265, 90, 10.1016/j.cancergen.2022.04.002 · DOI
  72. 2018, Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity, Cell Rep, 24, 2167, 10.1016/j.celrep.2018.07.058 · DOI
  73. 10.1371/journal.pcbi.1004274 · DOI · Paper page
  74. 10.1093/bioinformatics/btp324 · DOI · Paper page
  75. 10.1093/bioinformatics/bts271 · DOI · Paper page
  76. 10.1016/J.CELL.2021.04.048 · doi:10.1016/j.cell.2021.04.048 · Paper page
  77. 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L · DOI · Paper page
  78. 10.1073/pnas.1018854108 · DOI · Paper page

Cited by

See all 55

Metadata

Authors
Cotto, K. C., Feng, Y.-Y., Ramu, A., Richters, M., Freshour, S. L., Skidmore, Z. L., Xia, H., McMichael, J. F., Kunisaki, J., Campbell, K. M., Chen, T. H.-P., Rozycki, E. B., Adkins, D., Devarakonda, S., Sankararaman, S., Lin, Y., Chapman, W. C., Maher, C. A., Arora, V., Dunn, G. P., Uppaluri, R., Govindan, R., Griffith, O. L., & Griffith, M.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2018-10-05
OpenAlex
W2894831642
Cited by
55
References
5
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. https://app.cochat.ai/papers/10.1101/436634
The paper
Cotto, K. C., Feng, Y.-Y., Ramu, A., Richters, M., Freshour, S. L., Skidmore, Z. L., Xia, H., McMichael, J. F., Kunisaki, J., Campbell, K. M., Chen, T. H.-P., Rozycki, E. B., Adkins, D., Devarakonda, S., Sankararaman, S., Lin, Y., Chapman, W. C., Maher, C. A., Arora, V., . . . Griffith, M. (2018). RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/436634

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.